Advertisement

Spinal Tech

Omar Ishrak, chairman and CEO of Medtronic, responded to a series of articles attacking the company's original trials and promotion of recombinant human bone morphogenic protein-2, saying that integrity and patient safety are his highest priorities, according to a company…

Advertisement

The Senate Finance Committee has launched an investigation into the physicians who consulted with Medtronic on its Infuse after a recent study published in The Spine Journal showed a stronger correlation between the product and male infertility than was originally…

Advertisement